Pembrolizumab Plus Chemotherapy for First-Line Treatment of Advanced Triple-Negative Breast Cancer
FUTURE ONCOLOGY（2024）
关键词
chemotherapy,immune checkpoint inhibitors,immunotherapy,network meta-analysis,PD-1,PD-L1,survival outcomes,systematic review,triple-negative breast cancer
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要